TGFB1 and neoplasm: TGF-β1 and TGF-β2 mostly contribute to cancer progression by acting in both tumor cells and stromal cells [6], [7], and a loss of sensitivity to growth inhibition by TGF-β is thought to occur in most cancer cells.